Literature DB >> 3971299

Bronchopulmonary Kulchitzky cell carcinomas. A new classification scheme for typical and atypical carcinoids.

R R Paladugu, J R Benfield, H Y Pak, R K Ross, R L Teplitz.   

Abstract

Typical and atypical carcinoids constitute less than 5% of lung tumors. They and small cell undifferentiated lung cancers (SCLC) belong to the same family of apudomas arising from bronchopulmonary Kulchitzky cells. To reflect the overlap among these cancers, the authors suggest calling them Kulchitzky cell carcinomas (KCC); to indicate their spectrum of aggressiveness, the authors suggest calling typical carcinoids KCC-I, atypical carcinoids KCC-II, and small cell cancers KCC-III. One hundred fifty-six KCCs were reviewed: 115 were KCC-I and 41 were KCC-II. The ratio of women to men equals 2:1. At time of initial diagnosis, all patients with KCC-I, except one patient, were in Stage I. Among patients with KCC-II, 16 (39%) were in Stages II or III at time of presentation. The incidence of carcinoid syndrome was 1.9%. Treatment was lobectomy in 112 (72%) of patients, the remainder having lesser resections or pneumonectomy in approximately equal distribution. Our data cannot support the use of radical resection in the treatment of KCC because none of the patients died of local recurrence. The mean diameters of KCC-I and -II tumors were 1.5 and 2.8 cm, respectively. Increased mitotic activity and tumor necrosis were reliable criteria for diagnosing KCC-II. Electron microscopic examination did not help in differentiating KCC-I and KCC-II. Thorough sampling of the entire tumor was found to be mandatory for precise diagnosis and for differentiation from KCC-III (SCLC). Measurement of nuclear DNA was done using integrated optical density (IOD) by image analysis. The IODs of KCC-I, -II and -III were 1.36, 1.55 and 1.94, respectively. These significant differences (P less than 0.001) correlated with the aggressiveness of the cancers. Of patients with KCC-I, 1.7% succumbed to KCC; this included one patient reported to have died of KCC-III (SCLC). Of 41 patients with KCC-II, 11 (27%) died of KCC; this includes at least 3 deaths from KCC-III.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971299     DOI: 10.1002/1097-0142(19850315)55:6<1303::aid-cncr2820550625>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

Review 2.  Neuroendocrine differentiation in lung tumours.

Authors:  M N Sheppard
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

3.  Surgical treatment of hemoptysis.

Authors:  J R Benfield
Journal:  West J Med       Date:  1991-10

4.  Bronchial carcinoid tumor presenting as a thyroid nodule: an unusual clinical manifestation.

Authors:  A Chico; M C Pallarés; X Matías-Guiu; L Ciprés; M Puig-Domingo; S M Webb
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

Review 5.  Lung cancer--current concepts and controversies.

Authors:  S B Pett; J A Wernly; B F Akl
Journal:  West J Med       Date:  1986-07

6.  Misdiagnosed case of bronchial carcinoid presenting with refractory dyspnoea and wheeze: a rare case report and review of literature.

Authors:  Avradip Santra; Pravati Dutta; Sudarsan Pothal; Rekha Manjhi
Journal:  Malays J Med Sci       Date:  2013-05

7.  Prognostic value of nucleolar organizer regions in neuroendocrine tumours of the lung.

Authors:  J Böhm; V Kacic; P Gais; H W Präuer; H Höfler
Journal:  Histochemistry       Date:  1993-01

8.  Primary pulmonary carcinoid tumor with metastasis to endometrial polyp.

Authors:  Mazdak Momeni; Valentin Kolev; Dan Costin; Howard H Mizrachi; Linus Chuang; Richard R P Warner; Herbert F Gretz
Journal:  Int J Surg Case Rep       Date:  2012-10-17

9.  Endobronchial Carcinoid Tumor Totally Occluding the Left Main Bronchus Without Producing Symptoms of Bronchial Obstruction.

Authors:  Diamantis I Tsilimigras; Demetrios Moris; Ioannis Ntanasis-Stathopoulos; Davide Patrini; Nikolaos Panagiotopoulos
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

10.  Bronchopulmonary carcinoids and regional lymph node metastases. A quantitative pathologic investigation.

Authors:  F B Thunnissen; J Van Eijk; J P Baak; N W Schipper; A M Uyterlinde; R S Breederveld; S Meijer
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.